A Load of BS, Can't blame a CEO for the mistakes and say they had nothing to do with the successes, the Buck Stops on the CEO's Desk
"Kelly Whelan didn't have anything to do with getting FDA clearance."
KW took over BIEL in October 2019. The Musculoskeletal FDA Clearance was not granted until February 2020, You have No knowledge of KW's involvement in getting the FDA to approve this Clearance.
"Kelly Whelan didn't find any deals to have the product marketed - Nalepka and Staelin did all that."
First, Dr. Staelin did not rejoin BIEL until June 2020. KW made the decision to move to the OEM Business Plan which brought in the KT Tape Deal 12/2020, the DJO/Scott Deal 11/2020, the SAI/Airway Deal 3/2021, the CE Mark which opened the 440 million person EU Market. Once again you have No knowledge of KW's involvement in these deals which is also true for the Synergy Deal in Asia/MENA, 'Novro Med S.A. de C.V' Deal in Mexico, the Prim Group Deal in Spain, the Adcock Ingram Deal in S. Africa.
"Regardless, my post was about her qualifications to BECOME CEO - as in, what did she do before becoming CEO that qualifies her to run a publicly traded company?"
The Whelan Family, KW through IBEX & PW through St John's, own a controlling interest in BIEL via their $9.2 million in outstanding Loans. Add in Dr. Staelin's $857k in Loans and we clear $10 million. That is what gives the Whelans the right to say who heads the company. This is also why we had a relentless campaign in 2019 - 2020 for IBEX to forfeit the rights to 17 billion shares. with those shares gone a group of investors could pool their shares and take control of BIEL.
Whether one approves or disapproves of KW's decisions as CEO I will take her commitment to making the company that her father founded successful verses any corporate raiders wanting to take over BIEL.
